SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE429.25-3.85 (-0.89 %)
PREV CLOSE ( ) 433.10
OPEN PRICE ( ) 434.35
BID PRICE (QTY) 429.20 (319)
OFFER PRICE (QTY) 429.45 (86)
VOLUME 216313
TODAY'S LOW / HIGH ( )428.60 434.80
52 WK LOW / HIGH ( )391.1 678.8
NSE429.60-3.85 (-0.89 %)
PREV CLOSE( ) 433.45
OPEN PRICE ( ) 433.45
BID PRICE (QTY) 429.60 (226)
OFFER PRICE (QTY) 429.70 (21)
VOLUME 2649473
TODAY'S LOW / HIGH( ) 428.20 434.40
52 WK LOW / HIGH ( )390.6 679.3
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 01-03 1993
Management Info
Israel Makov - Chairman Dilip S Shanghvi - Managing Director
Registered Office

Address Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone 0265- 5515500 / 5515600 / 5515700

Email secretarial@sunpharma.com

Website www.sunpharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
15Dec Shanghvi Finance submits disclosure
The Exchange has received the disclosure under Regulation 31(1) and 31(2..
06Dec Shanghvi Finance submits disclosure
The Exchange has received the disclosure under Regulation 31(1) and 31(2..
06Dec Sun Pharmaceutical trades higher on th
Sun Pharmaceutical Industries is currently trading at Rs. 420.00, up by..
04Dec Sun Pharmaceutical Industries informs
Sun Pharmaceutical Industries has informed about clarification related t..
03Dec Sun Pharmaceutical gets US FDA approva
Sun Pharmaceutical Industries including its subsidiaries has received fi..
Financials
Rs. in Millions
QTR Sep 18 ANNUAL 18
Net Profit-9064.2-4945.9
Gross Profit -8955.1 -5199.8
Operating Profit 5926.112510.6
Net Sales 22992.579476
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Piramal Enterprises (BSE)
 2277.00 (4.30%)
M.Cap (Rs. in Cr)41878.52
Torrent Pharma (BSE)
 1766.70 (2.09%)
M.Cap (Rs. in Cr)29931.27
Merck (BSE)
 3052.50 (1.14%)
M.Cap (Rs. in Cr)5052.85
Valiant Organics (BSE)
 1450.00 (1.75%)
M.Cap (Rs. in Cr)850.33
Hester Biosciences (BSE)
 1160.00 (1.93%)
M.Cap (Rs. in Cr)986.80
Shareholding Pattern
PROMOTERS 54.38%
NON-INSTITUTION 12.31%
MUTUAL FUNDS/UTI 8.57%
FI/BANKS/INSURANCE 7.91%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal,Apurva Mittal, Tel no: 022-40790032,022 - 40790024, Mobile no- 9773104340,9768009000 E-mail id- Complaince@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.